HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

ACC 2017: CV Risk Factors

Research includes a possible link between Zika & CV issues, CV effects of cannabis use, and neurocognitive impairment with PCSK9 variants.

Presentations at the American College of Cardiology’s Annual Scientific Sessions included potential heart issues related to Zika infection, risk of stroke and heart failure with cannabis use, and neurocognitive impairment with PCSK9 variants.

slideshow image

ACC 2017: CV Risk Factors

slideshow image

Myocarditis, Heart Failure and Arrhythmias in Patients with Zika Abstract link.

slideshow image

Could infection with the Zika virus cause cardiovascular issues?

slideshow image

Larger, systematic studies are needed to understand Zika-related cardiac problems.

slideshow image

Cannabis Use Predicts Risks of Heart Failure and Cerebrovascular Accidents: Results from the National Inpatient Sample Abstract link.

slideshow image

What are the cardiovascular effects of cannabis use?

slideshow image

Cannabis use was independently associated with a 26% increase in stroke risk and 10% increase in heart failure.

slideshow image

PCSK9 Variants and Neurocognitive Impairment: Data from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study Abstract link.

slideshow image

Are PCSK9 loss-of-function (LOF) variants related to neurocognitive impairment?

slideshow image

Researchers saw no association between PCSK9 LOF variants and neurocognitive impairment.

PreviousNext